Literature DB >> 16798005

Cromolyn administration (to block mast cell degranulation) reduces necrosis of dystrophic muscle in mdx mice.

Hannah G Radley1, Miranda D Grounds.   

Abstract

Duchenne muscular dystrophy is a lethal muscle wasting disorder, resulting from mutations in the gene encoding for the skeletal muscle protein dystrophin. The absence of functional dystrophin leaves the muscle membrane vulnerable to damage during contraction. Damage initially occurs as 'tears' in the membrane, this damage can be exacerbated by the inflammatory response leading to myofibre necrosis rather than repair. Mast cells resident within skeletal muscle represent an immediate source of pro-inflammatory cytokines. We hypothesise that blockade of mast cell degranulation would reduce the extent of myofibre necrosis in the mdx mouse. Daily cromolyn injections were performed on young and exercised adult mdx mice and histological analysis confirmed that mast cell degranulation contributes to myofibre necrosis. This research identified high biological variation between individual mdx mice in the severity of the dystrophic pathology, and supported a relationship between extent of muscle damage in adult mdx mice and their individual enthusiasm for voluntary wheel running.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16798005     DOI: 10.1016/j.nbd.2006.03.016

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  36 in total

1.  Lesional and nonlesional skin from patients with untreated juvenile dermatomyositis displays increased numbers of mast cells and mature plasmacytoid dendritic cells.

Authors:  Sheela Shrestha; Barry Wershil; John F Sarwark; Timothy B Niewold; Teresa Philipp; Lauren M Pachman
Journal:  Arthritis Rheum       Date:  2010-09

Review 2.  Immunobiology of Inherited Muscular Dystrophies.

Authors:  James G Tidball; Steven S Welc; Michelle Wehling-Henricks
Journal:  Compr Physiol       Date:  2018-09-14       Impact factor: 9.090

3.  Age-related T2 changes in hindlimb muscles of mdx mice.

Authors:  Ravneet S Vohra; Sunita Mathur; Nathan D Bryant; Sean C Forbes; Krista Vandenborne; Glenn A Walter
Journal:  Muscle Nerve       Date:  2015-07-14       Impact factor: 3.217

4.  Proinflammatory macrophages enhance the regenerative capacity of human myoblasts by modifying their kinetics of proliferation and differentiation.

Authors:  Maximilien Bencze; Elisa Negroni; Denis Vallese; Houda Yacoub-Youssef; Soraya Chaouch; Annie Wolff; Ahmed Aamiri; James P Di Santo; Bénédicte Chazaud; Gillian Butler-Browne; Wilson Savino; Vincent Mouly; Ingo Riederer
Journal:  Mol Ther       Date:  2012-10-16       Impact factor: 11.454

5.  Effects of mast cell modulation on early host response to implanted synthetic meshes.

Authors:  S B Orenstein; E R Saberski; U Klueh; D L Kreutzer; Y W Novitsky
Journal:  Hernia       Date:  2010-06-05       Impact factor: 4.739

6.  Adaptive and nonadaptive responses to voluntary wheel running by mdx mice.

Authors:  Rachel M Landisch; Allison M Kosir; Steven A Nelson; Kristen A Baltgalvis; Dawn A Lowe
Journal:  Muscle Nerve       Date:  2008-10       Impact factor: 3.217

Review 7.  Pharmacologic management of Duchenne muscular dystrophy: target identification and preclinical trials.

Authors:  Joe N Kornegay; Christopher F Spurney; Peter P Nghiem; Candice L Brinkmeyer-Langford; Eric P Hoffman; Kanneboyina Nagaraju
Journal:  ILAR J       Date:  2014

Review 8.  Immune-mediated mechanisms potentially regulate the disease time-course of duchenne muscular dystrophy and provide targets for therapeutic intervention.

Authors:  Nicholas P Evans; Sarah A Misyak; John L Robertson; Josep Bassaganya-Riera; Robert W Grange
Journal:  PM R       Date:  2009-08       Impact factor: 2.298

9.  Genetic overexpression of Serpina3n attenuates muscular dystrophy in mice.

Authors:  Andoria Tjondrokoesoemo; Tobias Schips; Onur Kanisicak; Michelle A Sargent; Jeffery D Molkentin
Journal:  Hum Mol Genet       Date:  2016-01-06       Impact factor: 6.150

10.  Preclinical drug trials in the mdx mouse: assessment of reliable and sensitive outcome measures.

Authors:  Christopher F Spurney; Heather Gordish-Dressman; Alfredo D Guerron; Arpana Sali; Gouri S Pandey; Rashmi Rawat; Jack H Van Der Meulen; Hee-Jae Cha; Emidio E Pistilli; Terence A Partridge; Eric P Hoffman; Kanneboyina Nagaraju
Journal:  Muscle Nerve       Date:  2009-05       Impact factor: 3.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.